TrialBMC pulmonary medicine2026

Improved quality of life, reduced quantitative lung fibrosis in a trial of inhaled pirfenidone for idiopathic pulmonary fibrosis.

Grace Hyun J Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.